Home › Funds › Trails Edge Capital Partners, LP › OKUR
Trails Edge Capital Partners, LP position in OKUR
ONKURE THERAPEUTICS INC · Health Care
Trails Edge Capital Partners, LP reported holding 619,557 shares of OKUR (ONKURE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.7M, representing 0.24% of its reported portfolio and ranking #38 among its reported holdings. Trails Edge Capital Partners, LP has disclosed OKUR holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Trails Edge Capital Partners, LP's OKUR position evolved
Trails Edge Capital Partners, LP first disclosed a stake in OKUR in Q2 2026 at 1,438,456 shares (US$6.6M). Across 2 filings, Trails Edge Capital Partners, LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 619,557 shares valued at US$1.7M — a reduction of -818,899 shares quarter over quarter.. Notable position changes include a 57% trim in Q3 2026 (shares fell 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.44M | $6.56M | New |
| Q3 2026 | 619.56K | $1.69M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About OKUR and 13F data
OKUR (ONKURE THERAPEUTICS INC) is a Health Care company. 64 other funds we track also report a position in OKUR — the largest reported positions include BVF INC/IL (US$14.8M), StepStone Group LP (US$12.1M), ACORN CAPITAL ADVISORS, LLC (US$7.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding OKUR
- BVF INC/IL 3.24M sh · $14.76M · Q2 2026
- StepStone Group LP 2.66M sh · $12.13M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 2.84M sh · $7.75M · Q3 2026
- Vivo Capital, LLC 1.93M sh · $5.25M · Q3 2026
- Prosight Management, LP 1.33M sh · $3.61M · Q3 2026
- Sio Capital Management, LLC 1.08M sh · $2.95M · Q3 2026
- NEA Management Company, LLC 478.55K sh · $2.18M · Q2 2026
- Carlyle Group Inc. 269.89K sh · $735.46K · Q3 2026
- Stonepine Capital Management, LLC 162.82K sh · $443.68K · Q3 2026
- Aisling Capital Management LP 88.61K sh · $241.45K · Q3 2026
- Rosalind Advisors, Inc. 67.51K sh · $183.95K · Q3 2026
- Aldebaran Capital, LLC 39.36K sh · $107.25K · Q3 2026
More on Trails Edge Capital Partners, LP
FAQ
How long has Trails Edge Capital Partners, LP held OKUR?
Trails Edge Capital Partners, LP has disclosed OKUR holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Trails Edge Capital Partners, LP's current position in OKUR?
As of Q3 2026, Trails Edge Capital Partners, LP holds 619.56K shares of OKUR (ONKURE THERAPEUTICS INC), valued at $1.69M, representing 0.24% of its reported portfolio and ranking #38.
Has Trails Edge Capital Partners, LP been buying or selling OKUR?
In the latest 13F filing (Q3 2026), Trails Edge Capital Partners, LP reduced its position in OKUR.
Which other funds hold OKUR?
Other major institutional holders of OKUR include BVF INC/IL, StepStone Group LP, ACORN CAPITAL ADVISORS, LLC, among 64 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.